Dermot Kelleher
Direktor/Vorstandsmitglied bei Cellix Ltd.
Profil
Dermot P.
Kelleher is the founder of Opsona Therapeutics Ltd.
founded in 2004.
Currently, he is a Director at Cellix Ltd., The Institute of Molecular Medicine, and Dean at the University of British Columbia.
Previously, he served as an Independent Non-Executive Director at ICON plc from 2008 to 2019, Head of Medicine School at Trinity College Dublin from 2004 to 2012, Dean at Lee Kong Chian School of Medicine from 2012 to 2014, Principal-Faculty of Medicine at Imperial College London in 2015, and President at Federation of European Academies of Medicine.
Aktive Positionen von Dermot Kelleher
| Unternehmen | Position | Beginn |
|---|---|---|
Cellix Ltd.
 Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | - |
| The Institute of Molecular Medicine | Direktor/Vorstandsmitglied | 24.09.2009 |
| University of British Columbia | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Dermot Kelleher
| Unternehmen | Position | Ende |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Direktor/Vorstandsmitglied | 25.07.2019 |
| Lee Kong Chian School of Medicine | Corporate Officer/Principal | 01.01.2014 |
| Trinity College Dublin | Corporate Officer/Principal | 01.01.2012 |
| Federation of European Academies of Medicine | Präsident | - |
| Imperial College London | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
Cellix Ltd.
Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
| The Institute of Molecular Medicine | |
| Federation of European Academies of Medicine |
